![Frontiers | High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study Frontiers | High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study](https://www.frontiersin.org/files/Articles/676560/fmed-08-676560-HTML-r1/image_m/fmed-08-676560-g001.jpg)
Frontiers | High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study
![The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors - ScienceDirect The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1684118221000086-gr1.jpg)
The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors - ScienceDirect
![Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know - ScienceDirect Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S017129852300061X-ga1.jpg)
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know - ScienceDirect
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test among military and civilian personnel of an Air Force airport in central Italy | PLOS ONE
![Diagnostic performance of the Elecsys SARS‐CoV‐2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single‐center evaluation - Mueller - 2021 - Journal of Clinical Laboratory Diagnostic performance of the Elecsys SARS‐CoV‐2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single‐center evaluation - Mueller - 2021 - Journal of Clinical Laboratory](https://onlinelibrary.wiley.com/cms/asset/6fc3ace0-2602-4150-8269-18ee6ea8d2a4/jcla23906-fig-0001-m.jpg)
Diagnostic performance of the Elecsys SARS‐CoV‐2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single‐center evaluation - Mueller - 2021 - Journal of Clinical Laboratory
![Tampone Molecolare RT-PCR con QR CODE con codice CUN per ottenere il Green Pass - Tamponi salivari - Test Rapidi Antigenici con Indice COI di II e III Generazione - Test Sierologici - Tampone Molecolare RT-PCR con QR CODE con codice CUN per ottenere il Green Pass - Tamponi salivari - Test Rapidi Antigenici con Indice COI di II e III Generazione - Test Sierologici -](https://artemisialab.it/wp-content/uploads/2021/10/Tampone-molecolare-Tampone-salivare-Tampone-rapido-Antigenico-2.png)
Tampone Molecolare RT-PCR con QR CODE con codice CUN per ottenere il Green Pass - Tamponi salivari - Test Rapidi Antigenici con Indice COI di II e III Generazione - Test Sierologici -
![Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting? – ScienceOpen Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting? – ScienceOpen](https://www.scienceopen.com/document_file/f3c18e19-2ffb-44bd-9c49-51af8a69e85e/PubMedCentral/large.png)
Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting? – ScienceOpen
![Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories | Journal of Clinical Microbiology Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories | Journal of Clinical Microbiology](https://journals.asm.org/cms/asset/4d12f368-a98a-4232-89de-ba648cbdc65a/jcm.2021.59.issue-5.cover.gif)
Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories | Journal of Clinical Microbiology
![Frontiers | Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 Frontiers | Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19](https://www.frontiersin.org/files/MyHome%20Article%20Library/620222/620222_Thumb_400.jpg)
Frontiers | Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test among military and civilian personnel of an Air Force airport in central Italy | PLOS ONE
![Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection | Journal of Clinical Microbiology Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection | Journal of Clinical Microbiology](https://journals.asm.org/cms/asset/10b37b05-a09e-4ec5-8eb6-302c91ad6422/jcm.2021.59.issue-9.cover.gif)
Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection | Journal of Clinical Microbiology
![Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine](https://www.thelancet.com/cms/attachment/789ac3b8-2af4-467f-9613-b4524ebd688e/gr1.jpg)
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine
![Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine](https://www.thelancet.com/cms/asset/6bb7312f-dd8a-4b7a-ac75-36b65038980c/gr2.jpg)
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine
![Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection | Scientific Reports Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-04279-4/MediaObjects/41598_2021_4279_Fig1_HTML.png)
Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection | Scientific Reports
![Frontiers | Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic Frontiers | Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic](https://www.frontiersin.org/files/Articles/642318/fmed-08-642318-HTML/image_m/fmed-08-642318-g001.jpg)
Frontiers | Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic
![Impact of the COVID-19 Pandemic on Radiation Oncology Departments in Brazil - Advances in Radiation Oncology Impact of the COVID-19 Pandemic on Radiation Oncology Departments in Brazil - Advances in Radiation Oncology](https://www.advancesradonc.com/cms/asset/6384f31e-6731-4f53-8312-6b9a77157f5e/gr1.jpg)
Impact of the COVID-19 Pandemic on Radiation Oncology Departments in Brazil - Advances in Radiation Oncology
![Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020](https://www.mdpi.com/biomolecules/biomolecules-11-00425/article_deploy/html/images/biomolecules-11-00425-g001.png)
Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020
![Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020](https://www.mdpi.com/biomolecules/biomolecules-11-00425/article_deploy/html/images/biomolecules-11-00425-g001-550.jpg)
Biomolecules | Free Full-Text | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020
![JCM | Free Full-Text | Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients JCM | Free Full-Text | Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients](https://www.mdpi.com/jcm/jcm-09-02268/article_deploy/html/images/jcm-09-02268-g001.png)
JCM | Free Full-Text | Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients
![German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance | Communications Medicine German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance | Communications Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43856-022-00100-z/MediaObjects/43856_2022_100_Fig1_HTML.png)
German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance | Communications Medicine
![Clinical validation of a second generation anti‐SARS‐CoV‐2 IgG and IgM automated chemiluminescent immunoassay - Pieri - 2021 - Journal of Medical Virology - Wiley Online Library Clinical validation of a second generation anti‐SARS‐CoV‐2 IgG and IgM automated chemiluminescent immunoassay - Pieri - 2021 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/98a4fe36-86aa-40b7-9c24-898bd11797a4/jmv.v93.4.cover.jpg?trick=1688732102215)
Clinical validation of a second generation anti‐SARS‐CoV‐2 IgG and IgM automated chemiluminescent immunoassay - Pieri - 2021 - Journal of Medical Virology - Wiley Online Library
![Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor | PNAS Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor | PNAS](https://www.pnas.org/cms/asset/aaca8080-5459-4042-bc24-2e5a7bc630bd/keyimage.jpg)
Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor | PNAS
![Menarini Diagnostics > Home > Professional Diagnostics > COVID-19 > Antibody Detection > The AFIAS Range of POCT Analysers > Learn more Menarini Diagnostics > Home > Professional Diagnostics > COVID-19 > Antibody Detection > The AFIAS Range of POCT Analysers > Learn more](https://www.menarinidiagnostics.com/portals/20/immagini_prodotti_laboratory/AFIAS/chart4.png?ver=2020-09-18-082734-237)
Menarini Diagnostics > Home > Professional Diagnostics > COVID-19 > Antibody Detection > The AFIAS Range of POCT Analysers > Learn more
![The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States - Advances in Radiation Oncology The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States - Advances in Radiation Oncology](https://advancesradonc.com/cms/asset/78b22453-cf37-40f3-a64a-b873946e86f8/gr1.jpg)
The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States - Advances in Radiation Oncology
![Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies - eBioMedicine Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies - eBioMedicine](https://www.thelancet.com/cms/asset/4f5d4e3e-965e-416e-879a-5bcca1d83074/gr1.jpg)
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies - eBioMedicine
![Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43856-021-00012-4/MediaObjects/43856_2021_12_Fig1_HTML.png)
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine
![Coronavirus (COVID-19) – COSA SIGNIFICA IL RISULTATO DEL MIO TEST ANTIGENICO RAPIDO? (RAT results) | Australian Government Department of Health and Aged Care Coronavirus (COVID-19) – COSA SIGNIFICA IL RISULTATO DEL MIO TEST ANTIGENICO RAPIDO? (RAT results) | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/publications/2022/03/coronavirus-covid-19-cosa-significa-il-risultato-del-mio-test-antigenico-rapido-rat-results.jpg)